Wednesday, June, 19, 2024 10:11:16
  • The collaboration aims to further enhance the deployment, management as well as operations of different IoT devices.


  • The merged solution facilitates a simple architecture for the scalable management & tracking of the IoT asset to reduce cost & complexity.

HID Global (HID), an American secure identity solutions provider, has reportedly signed a collaboration agreement with Mist Systems (Mist), a pioneer in Artificial Intelligence (AI) powered wireless networks to merge Bluetooth Low Energy (BLE) location services with WLAN.

Reports cite, the two firms aim to converge the two technologies in an effort to further enhance the deployment, management as well as operations of different Internet of Things (IoT) devices.

According to a press release by HID Global, with HID Location Services which are enabled by Bluvision, a part of HID Global, the company is driving innovation across the IoT space as prominent market leaders in the field of sensor beacons for event & workflow management. Meanwhile, the Mist Learning WLAN is the company’s single, converged microservice platform based on the cloud for Wi-Fi & BLE-based indoor location services, removing the need for cost-heavy overlay platforms as well as battery-powered gateways for user engagement & asset location.

The merged solution reportedly facilitates a simple architecture to enable scalable management & tracking of the IoT asset to eliminate complexity, reduce cost and foster the accelerated adoption if the technology across organizational functions as well as use cases.

The V.P. of Sales, Bluvision, Rom Eizenberg stated that a typical hospital has more than 20 different use cases today for IoT management & tracking that could drive profitability, patient care as well as the overall patient experiences. Eizenberg further stated, the introduction of AI-powered indoor-location capabilities through standards-based BLE makes the launch of these services more cost-effective & scalable while reducing barriers to entry for a plethora of clinical scenarios that were locked out previously and could not benefit from these capabilities.

According to reports, the financial details related to the collaboration agreement have not been unveiled by the companies yet.